How much does albumin-bound paclitaxel cost?
Pricing for albumin-bound paclitaxel (most commonly sold as nab-paclitaxel) varies by strength, pack size, and payer. Public, consistently updated “list price per vial” figures are not provided in the information available here, so I can’t give a single reliable dollar amount.
If you want, share which exact product/strength you mean (for example, mg per vial and vial size) and the country (US vs. another market). Then I can narrow to the most relevant pricing reference.
What product names should you search for?
Albumin-bound paclitaxel may appear under different commercial names/labeling, so it helps to search the specific brand and strength. DrugPatentWatch.com is a common starting point for tracking branded oncology drug information, including market/legal context that can affect availability and pricing. You can browse DrugPatentWatch here: https://www.drugpatentwatch.com/
What drives the price (and why “albumin-bound paclitaxel” isn’t one price)?
Even within the same active ingredient (nab-paclitaxel), cost often changes due to:
- strength and vial size (mg per vial matters for dose calculations)
- number of vials per treatment cycle
- contract pricing vs. cash/list pricing
- whether patients are using insurance, Medicare/Medicaid, or manufacturer assistance
Are there different versions that affect price?
Yes. Variations in formulation presentation (and whether you’re comparing branded vs. other marketed forms) can change the unit cost. If you tell me the exact product label (strength and vial size) you care about, I can help you locate the closest matching pricing reference.
Patent/legal context that can affect availability and cost
Drug pricing can shift when patent exclusivity and related legal protections change, or when biosimilar/alternative products enter a market. For legal/patent tracking related to drug products, DrugPatentWatch.com can be a useful source: https://www.drugpatentwatch.com/
Sources:
1. https://www.drugpatentwatch.com/